Egyptian firm to market anti-AIDS drug
An Egyptian pharmaceuticals company has recently announced that it would soon begin marketing two new low-cost generic drugs for treating AIDS and Leukemia patients, reported Al-Quds Al-Arabi daily.
The cost of the new Egyptian drugs is significantly lower than that of similar foreign brands imported into the Middle East and Africa from the West.
The Nile Pharmaceuticals Company reported that both products would be available on local markets as of next July for costs averaging 40 percent less than that of competing products. Thirty-seven percent of the company is listed on the stock exchange, while the rest is state-owned.
According to <>Reuters<>, the multinational drug industry has come under attack in recent months for trying to protect patents on high-priced drugs that are unaffordable for millions suffering in poorer countries from AIDS and other diseases. ― (MENA Report)
© 2001 Mena Report (www.menareport.com)
- Nile Pharmaceuticals posts 8.8 percent net profit fall in 1Q01
- Multinationals pressure Egyptian pharmaceutical industry
- Egyptian health minister: Pharmaceutical market is stable
- S&P’s revises outlook for Israel’s Teva Pharmaceutical Industries to negative
- Cooperation in drug production may facilitate future mergers